SPOTLIGHT -
Slideshow
Author(s):
Depression predominates across the lifespan in patients with bipolar disorder. Here: A discussion about (and beyond) the four FDA-approved drugs to treat symptoms.
Positive Results in Phase 2b Trial of Psychedelic Agent GH001 for Treatment-Resistant Depression
Blue Light Blockers: A Behavior Therapy for Mania
January in Review: Updates on the Psychiatric Treatment Pipeline
Blue Light, Depression, and Bipolar Disorder
Virtual Reality Meditation for Major Depressive Disorder and Generalized Anxiety Disorder
A Prescription for Loneliness: Mitigating Social Isolation and Loneliness in Older Adults